IL-33 is predominantly present in stromal cells, including fibroblasts, cancer-associated fibroblasts (CAF), pericytes, and mesenchymal stromal cells; furthermore, endothelial and epithelial cells express it, as well as smooth muscle cells and specific populations of hematopoietic cells, such as macrophages [2,9,10]. This evidence concerns the gene IL33 and cancer.